![]() Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | ![]() Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |||
Founding Date | Founding Date 1996 | Founding Date 2006 | Founding Date 1998 | Founding Date 2002 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations South San Francisco, US HQ |
Employees | Employees 1983% decrease | Employees 21316% decrease | Employees 29843% increase | Employees 58415% increase | Employees 11914% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 97.4 m | Valuation ($) N/A | Valuation ($) 3.1 b | Valuation ($) N/A |
Employee Rating | Employee Rating 3.1 | Employee Rating 3.4 | Employee Rating 3.5 | Employee Rating 2.9 | Employee Rating 4 |
Financial | |||||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $90.2m (FY, 2022) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) $329.2m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $67.1m (FY, 2022) | Cost of goods $59.4m (FY, 2018) | Cost of goods $38.6m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit $23.1m (FY, 2022) | Gross profit $114.4m (FY, 2018) | Gross profit $290.6m (FY, 2022) | Gross profit N/A |
Net income | Net income N/A | Net income ($19.9m) (FY, 2022) | Net income ($147.7m) (FY, 2018) | Net income ($236.6m) (FY, 2022) | Net income ($176.6m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 88m | Total funding raised $ 157m |
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View companyArray BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View companyAmicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companyTricida operates in the healthcare industry focusing on pharmaceutical business.
View company